RESEARCH-USE BIOSIMILAR ANTIBODY
Loncastuximab
Antibody-drug conjugate · IgG1
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab has antitumor activity and can be used in the research of Non-Hodgkin Lymphoma (NHL) and Diffuse Large B-cell Lymphoma (DLBCL). Loncastuximab is capable of synthesizing the ADC molecule Loncastuximab tesirine (HY-P99349).
TARGETCD19
YAntibody-drug conjugate
CATALOGSC-BS-417
CATALOG NUMBERSC-BS-417
MOLECULAR WEIGHTApprox. 144.46 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab has antitumor activity and can be used in the research of Non-Hodgkin Lymphoma (NHL) and Diffuse Large B-cell Lymphoma (DLBCL). Loncastuximab is capable of synthesizing the ADC molecule Loncastuximab tesirine (HY-P99349).
Loncastuximab is a recombinant research-use antibody directed against CD19.